Although the highest S100B concentration in the group of T2DM patients whose blood was collected after COVID-19 was only 700 pg/mL, this protein was detectable at CS100B ≥ 7.8 pg/mL in 79% of participants in the group. This evidence concerns the gene S100B and type 2 diabetes mellitus.